The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Evaluation of Hepatitis C Treatment Outcomes Among Patients Enrolled in Outpatient Parenteral Antibiotic Therapy-Boston, Massachusetts, 2016-2021
Open Forum Infect Dis. 2023 Jul 5;10(7):ofad342. doi: 10.1093/ofid/ofad342.eCollection 2023 Jul.
1Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
2Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
3Division of Infectious Diseases, Brigham & Women's Hospital, Boston, Massachusetts, USA.
Abstract
In our Boston-based outpatient parenteral antibiotic therapy (OPAT) program between 2016 and 2021, we found that a low proportion of patients with active hepatitis C virus (HCV) were prescribed HCV treatment by their OPAT provider and few achieved sustained virologic response. Clinicians should consider concurrent HCV treatment during OPAT.